Medical treatment improves social behavior in a primate endometriosis model (Callithrix jacchus)
article
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
Medical treatment for endometriosis in marmosets significantly improved social and self-grooming behaviors, restoring them to levels comparable to healthy animals.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: As endometriosis is known to be very painful in humans, therapeutic studies should consider pain-related aspects in experimental animals too. In a previous study, we found that common marmosets suffering from endometriosis show remarkable deviations in social behavior and cognitive tasks. METHODS: Female marmosets with endometriosis undergoing medical treatment were tested vs. two control groups (healthy and endometriosis monkeys without treatment) concerning behavioral aspects, cognitive skills, and mobility. RESULTS: The treated monkeys performed significant more social and self-grooming, comfort behavior and were more active than the untreated endometriosis monkeys. The treated marmosets even returned to equal levels as their healthy conspecifics. Cognitive and mobility tests revealed no significant differences. CONCLUSIONS: A beneficial effect of the applied endometriosis medication on behavioral impairments could be obtained. Including such measurements in therapeutic research contributes to aspects of animal welfare and pain-relieving potential of the tested compound.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (34)
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Angiogenese und Endometriose via openalex
- Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target via openalex
- Behavioral tests as indicator for pain and distress in a primate endometriosis model via openalex
- Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
- Endometriosis: The way forward via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Estrogen metabolizing enzymes in endometrium and endometriosis via openalex
- Estrogen Production and Metabolism in Endometriosis via openalex
- Experimental endometriosis reduction in rats treated with pioglitazone via openalex
- Incidence, symptoms, and signs of endometriosis in fertile and infertile women. via openalex
- Increased Production of 17β-Estradiol in Endometriosis Lesions Is the Result of Impaired Metabolism via openalex
- Induction of endometriosis in the marmoset monkey (Callithrix jacchus) via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Psychosocial aspects of endometriosis: A review via openalex
- Recombinant human TNF binding protein-1 (r-hTBP-1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. via openalex
- W4285719527 via openalex
- W643309395 via openalex
- W1512318310 via openalex
- W1967920937 via openalex
- W1993354065 via openalex
- W2022934326 via openalex
- W2046640023 via openalex
- W2058878968 via openalex
- W2109403179 via openalex
- W2126166718 via openalex
- W2163199041 via openalex
- W2313573485 via openalex
- W2331810762 via openalex
- W2412673684 via openalex
- W2613614797 via openalex
- W635083542 via openalex
Cited by (3)
- An irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 inhibits estradiol synthesis in human endometriosis lesions and induces regression of the non-human primate endometriosis 2022
- Overexpression of Human Estrogen Biosynthetic Enzyme Hydroxysteroid (17beta) Dehydrogenase Type 1 Induces Adenomyosis-like Phenotype in Transgenic Mice 2022
- Inhibition of Type 1 17β-Hydroxysteroid Dehydrogenase Impairs the Synthesis of 17β-Estradiol in Endometriosis Lesions 2013
Source provenance
- europepmc
- last seen: 2026-10-04T09:26:46.659050+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:19:12.052662+00:00
- unpaywall
- last seen: 2026-10-04T06:29:23.997191+00:00
License: CC0
· commercial use OK